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Abstract 
Herein, we report the synthesis and spectroscopic characterization of novel Near Infra-Red (NIR) 
pentamethine cyanine dyes, as potential photosensitizers for Photodynamic Therapy (PDT) 
characterized by a strong absorption in the tissue transparency window (600-800 nm). The 
heteroaromatic benzoindolenine ring of various symmetrical cyanine dyes has been differently 
functionalized and quaternarized as a result of a structure-activity study and to determine the substituent 
effect on the cellular uptake, ROS production and photodynamic activity. These probes present low 
cytotoxicity in dark, but promote phototoxic effect, upon irradiation, in human fibrosarcoma cell line 
(HT-1080) with interesting and unexpected structure to property activity. 
1. Introduction 
NIR dyes had a significant development in bioanalytical or biologically related applications in recent 
years with a particular focus on in vivo fluorescence imaging due to the low self-fluorescence of the 
biological molecules in the NIR region of the electromagnetic spectrum. [1,2] NIR polymethine dyes, 
such as pentamethine and heptamethine cyanines and squaraines, are well suited for this purpose and 
have been extensively studied for these applications.[3–7] The same strengths that have promoted their 
development as NIR probes, make these dyes potential candidates as photosensitizers in photodynamic 
therapy (PDT).[8–11] PDT is a minimally invasive approach exploiting the biological consequences of 
localized oxidative damage generated by photodynamic processes.[12] Every initial photodynamic 
process is characterized by the presence of a light-activated drug called photosensitizer (PS), light and 
oxygen. The PS is excited by a non-thermal light (i.e. LED) at the appropriate excitation wavelength, 
upon a certain time (drug-to-light interval, DLI) from the administration to the patient. The deactivation 
of the PS excited state (PS*) occurs mainly by two photochemical processes of relevance in PDT: 
photoelectric electron transfer or energy transfer from PS* to another molecule like molecular oxygen, 
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generating reactive oxygen species (ROS) such a singlet oxygen 1O2.[13–15] An appropriate choice of 
the PS is of great importance to maximize the treatment effectiveness by high ROS production. 
Among the proposed PS,[16,17] polymethine and cyanine dyes, show the desired characteristics of 
PDT-active photosensitizer.[18] In particular, the easiness in designing NIR molecules provides 
cyanines with absorption in the phototherapeutic window (600-850 nm). Several in vivo imaging and 
PDT studies using heptamethine cyanine and squaraine dyes have been previously reported.[8,19–21] 
Unsubstituted indolenine- and benzoindolenine-based heptamethinic cyanines have been reported to 
preferentially accumulate in tumor tissues[3,22]. This interesting observation prompted us to further 
explore the biological properties of substituted benzoindolenine ring derivatives. In regards to the 
substituent nature, two to six carbon length side alkyl chains has been reported to optimize the 
internalization and retention processes in cell.[3,23] The heavy atom effect is usually addressed by 
insertion, along the molecular scaffold, of bromine atoms which promotes the intersystem conversion 
in the excited triplet state of the dye increasing the ROS generation. Similar effect was recently 
described also for squaraine-based PSs.[8,20] 
In the present work we investigated the photodynamic potential of a new series of NIR dyes. A new 
series of NIR symmetrical cyanine dyes, based on a benzoindoleninic ring (Fig. 1), was synthetized and 
photophysically characterized before being in vitro tested for the evaluation of their cytotoxicity and 
photo-toxicity. 
The heteroaromatic benzoindolenine ring of various symmetrical cyanine dyes has been differently 
substituted and quaternarized to implement a structure-activity study and to determine the substitutions 
influence on the cellular uptake, ROS production and photodynamic activity. 
 
Figure 1. Structures of the synthesized symmetrical cyanine dyes. 
2. Experimental details 
2.1 Materials and techniques 
All the chemicals were purchased from Sigma Aldrich, Fluka, Merck or Riedel de Haen and were used 
without any further purification. 
All microwave reactions were performed in single-mode Biotage Initiator 2.5. TLC were performed on 
silica gel 60 F254 plates. ESI-MS spectra were recorded using a LCQ Thermo Advantage Max 
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spectrometer, with electrospray interface and ion trap as mass analyzer. The flow injection effluent was 
delivered into the ion source using nitrogen as sheath and auxiliary gas. 1H NMR (200 MHz) and 13C 
NMR (50 MHz) spectra were recorded on a Bruker Avance 200 NMR in CDCl3 or DMSO-d6. 
2.2. Procedure for the preparation of compounds 1-4 
2.2.1. (6-bromonaphthalen-2-yl)hydrazine (1) 
6-bromonaphthalen-2-ol (21.15 g, 0.95 mol) is cooled down to 0°C in a three-neck flask before 
hydrazine hydrate (55.18 ml, 1.14 mol) is added drop by drop. The suspension is warmed up to 60-80°C 
to obtain a clear yellow solution and the reaction is run at 125°C for 24 h. After 24 h, the dark orange 
reaction mixture is cooled down to 60°C (below this temperature an undesired phase separation takes 
place). The hot solution is then poured drop by drop in n-propanol. The suspended solid is filtered and 
washed with n-propanol to provide (6-bromonaphthalen-2-yl)hydrazine (1) as a white/yellow solid 
(3.77 g, 16% yield). 
2.2.2. 7-bromo-1,1,2-trimethyl-1H-benzo[e]indole (2b) 
(6-bromonaphthalen-2-yl)hydrazine (1) (3.23 g, 13.64 mmol), 3-methylbutan-2-one (4.38 ml, 40.92 
mmol) and glacial acetic acid (15 ml) are introduced in a microwave reaction vial, sealed with a crimp 
cap and heated in the microwave system at 160°C for 10 min. The brown solution is left to cool down 
and the acetic acid is removed under vacuum. The oily residue is partitioned between diethyl ether (50 
ml) and water (150 ml). The aqueous phase is washed three times with petroleum ether (3 x 50 ml). The 
combined organic solutions are dried and evaporated under vacuum to afford 7-bromo-1,1,2-trimethyl-
1H-benzo[e]indole 2b (3.56 g, yield = 90%) as a brown orange oil. 
1H NMR (200MHz, CDCl3), δ: 8.14 (t, J = 4.3 Hz, 1H), 7.85 (dt, J = 14.9, 6.6 Hz, 3H), 7.64 (dd, J = 
9.0, 2.0 Hz, 1H), 2.49 (s, 3H), 1.57 (s, 6H). 
13C NMR (50MHz, CDCl3), δ: 189.46, 150.56, 138.41, 132.88, 131.03, 129.12, 127.47, 126.56, 123.56, 
120.46, 117.70, 76.52, 75.89, 54.81, 22.21. 
MS (ESI) [M+H]+  288.10  
2.2.3. N-((1E,2E)-3-(phenylamino)allylidene)benzenaminium chloride (3) 
Compound 3 was prepared as previously described.[24] 
1H NMR (200MHz, DMSO-d6), δ: 12.35 (s, 2H), 8.76 (d, J = 11.3 Hz, 2H), 7.57 – 7.15 (m, 10H), 6.34 
(t, J = 11.4 Hz, 1H). 
2.2.4. Synthesis of intermediates (4a) and (4b) 
The intermediate 3-ethyl-1,1,2-trimethyl-1H-benzo[e]indol-3-ium iodide (4a) and 3-butyl-1,1,2-
trimethyl-1H-benzo[e]indol-3-ium iodide (4b) were prepared as previously described, starting from 
commercially available 2a.[25] 
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2.2.4.1. Synthesis of 3-ethyl-1,1,2-trimethyl-1H-benzo[e]indol-3-ium iodide (4a) 
1H NMR (200 MHz, DMSO) δ 8.50 – 8.02 (m, 8H), 7.90 – 7.60 (m, 4H), 4.61 (q, J = 7.1 Hz, 4H), 2.93 
(s, 5H), 1.75 (s, 11H), 1.49 (t, J = 7.2 Hz, 6H). 
2.2.4.2. 3-butyl-1,1,2-trimethyl-1H-benzo[e]indol-3-ium iodide (4b) 
MS (ESI) [M−I]+ 266.16 
1H NMR (200MHz, DMSO-d6), δ: 8.28 (dt, J = 21.6, 8.6 Hz, 4H), 7.86 – 7.68 (m, 2H), 4.59 (t, J = 7.5 
Hz, 2H), 2.91 (d, J = 17.5 Hz, 3H), 2.04 – 1.80 (m, 2H), 1.77 (s, 6H), 1.48 (dd, J = 15.8, 7.3 Hz, 2H), 
0.97 (t, J = 6.0 Hz, 3H). 
2.3. General quaternization synthesis of bromobenzoindolenine 
7-bromo-1,1,2-trimethyl-1H-benzo[e]indole (2b), iodoalkane (4 equivalents), and acetonitrile were 
introduced in a reaction vial, sealed with a crimp cap and heated in microwave system at 155°C for 45 
min. The reaction mixture was then poured in diethyl ether (200 ml) to precipitate a brown/green solid 
which was washed with diethyl ether and filtered. 
2.3.1. 7-bromo-3-ethyl-1,1,2-trimethyl-1H-benzo[e]indol-3-ium iodide (4c) 
7-bromo-1,1,2-trimethyl-1H-benzo[e]indole (2) (1 g, 3,48 mmol), iodoethane (1,94 ml, 13,9 mmol) and 
anhydrous acetonitrile (15 ml). 
1.19 g, yield = 78%. 
1H NMR (200MHz, DMSO-d6), δ: 8,54 (d, J = 2,1 Hz, 1H), 8,29 (dt, J = 16,4, 9,0 Hz, 3H), 7,88 (dd, J 
= 9,0, 1,9 Hz, 1H), 4,60 (q, J = 7,0 Hz, 2H), 2,89 (s, 3H), 1,74 (s, 6H), 1,49 (t, J = 7,3 Hz, 3H). 
13C NMR (50MHz, DMSO-d6), δ: 196.70, 138.93, 134.51, 131.82, 131.52, 130.26, 126.08, 125.95, 
120.78, 114.82, 55.78, 43.70, 21.71, 14.00, 13.10. 
2.3.2. 7-bromo-3-butyl-1,1,2-trimethyl-1H-benzo[e]indol-3-ium iodide (4d) 
7-bromo-1,1,2-trimethyl-1H-benzo[e]indole (2) (1 g, 3,48 mmol), iodobutane (1,58 ml, 13,9 mmol) and 
anhydrous acetonitrile (15 ml). 
1.05 g, yield = 64%. 
1H NMR (200MHz, DMSO-d6), δ: 8,53 (d, J = 1,9 Hz, 1H), 8,28 (dt, J = 15,4, 9,0 Hz, 3H), 7,87 (dd, J 
= 9,0, 2,0 Hz, 1H), 4,56 (t, J = 7,7 Hz, 2H), 2,93 (s, 3H), 1,98 – 1,77 (m, 2H), 1,74 (s, 6H), 1,43 (dt, J 
= 14,7, 7,4 Hz, 2H), 0,94 (t, J = 7,3 Hz, 3H). 
13C NMR (50MHz, DMSO-d6), δ: 197.02, 139.22, 137.54, 134.52, 131.83, 131.54, 130.23, 126.04, 
125.98, 120.82, 114.98, 55.81, 48.06, 29.71, 21.85, 19.59, 14.19, 13.90. 
2.4. General synthesis of symmetrical cyanines 
Compounds 4a-d (2 mol), N-((1E,2E)-3-(phenylamino)allylidene)benzenaminium chloride (3) (1 mol), 
anhydrous sodium acetate (3 mol) and acetic anhydride were introduced in a microwave vial and heated 
at 130°C for 10-20 min. The reaction mixture was poured in diethyl ether to precipitate a blue solid, 
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which was washed with diethyl ether and filtered. The blue solid was dissolved in DCM leaving 
unreacted sodium acetate crystals on the filter funnel. The filtrate was evaporated under vacuum to 
obtain the cyanine dyes as a blue powder. 
2.4.1. Dye 5 
3-ethyl-1,1,2-trimethyl-1H-benzo[e]indol-3-ium iodide (4a) (500 mg, 1.37 mmol), N-((1E,2E)-3-
(phenylamino)allylidene)benzenaminium chloride (3) (177 mg, 0.68 mmol), anhydrous sodium acetate 
(169 mg, 2.05 mmol) and acetic anhydride (15 ml) were introduced in a microwave vial and heated at 
130°C for 20 min. 5 as a blue powder (375 mg, yield = 86%). 
MS (ESI) [M−I]+ 511.28. 
1H NMR (200MHz, DMSO-d6), δ: 8.46 (t, J = 13.1 Hz, 2H), 8.26 (d, J = 8.3 Hz, 2H), 8.07 (dd, J = 8.2, 
5.4 Hz, 4H), 7.70 (dd, J = 16.4, 8.1 Hz, 4H), 7.57 – 7.44 (m, 2H), 6.63 (t, J = 12.2 Hz, 1H), 6.37 (d, J = 
13.9 Hz, 2H), 4.28 (d, J = 7.0 Hz, 4H), 1.93 (d, J = 10.8 Hz, 12H), 1.33 (t, J = 7.0 Hz, 6H). 
13C NMR (50MHz, DMSO-d6) δ: 173.48, 153.27, 139.55, 133.50, 131.55, 130.64, 130.21, 128.00, 
127.89, 125.78, 125.03, 122.38, 111.66, 102.79, 50.99, 26.95, 12.73.  
2.4.2. Dye 6 
3-butyl-1,1,2-trimethyl-1H-benzo[e]indol-3-ium iodide (4b) (1 g, 2.54 mmol), N-((1E,2E)-3-
(phenylamino)allylidene)benzenaminium chloride (3) (329 mg, 1.27 mmol), anhydrous sodium acetate 
(313 mg, 3.81 mmol) and acetic anhydride (15 ml) were introduced in a microwave vial and heated at 
130°C for 20 min. 6 as a blue-violet powder (694 mg, yield = 79%). 
MS (ESI) [M−I]+ 567.52. 
1H NMR (200MHz, DMSO-d6), δ:  8.47 (t, J = 13.1 Hz, 2H), 8.26 (d, J = 8.8 Hz, 2H), 8.07 (dd, J = 8.2, 
4.0 Hz, 4H), 7.71 (dd, J = 17.2, 8.1 Hz, 4H), 7.57 – 7.46 (m, 2H), 6.66 (t, J = 12.4 Hz, 1H), 6.38 (d, J 
= 13.6 Hz, 2H), 4.24 (t, J = 7.5 Hz, 4H), 1.94 (d, J = 12.1 Hz, 12H), 1.82 – 1.64 (m, 4H), 1.53 – 1.33 
(m, 4H), 0.95 (t, J = 7.2 Hz, 6H). 
13C NMR (50MHz, DMSO-d6) δ: 173.89, 153.09, 139.98, 133.40, 131.53, 130.57, 130.19, 128.01, 
127.85, 125.05, 122.42, 111.90, 103.24, 50.96, 43.60, 29.66, 27.06, 19.73, 14.06. 
2.4.3. Dye 7 
7-bromo-3-ethyl-1,1,2-trimethyl-1H-benzo[e]indol-3-ium iodide (4c) (500 mg, 1.13 mmol), N-
((1E,2E)-3-(phenylamino)allylidene)benzenaminium chloride (3) (146 mg, 0.56 mmol), anhydrous 
sodium acetate (139 mg, 1.69 mmol) and acetic anhydride (15 ml) were introduced in a microwave vial 
and heated at 130°C for 10 min. 7 as a blue powder (353 mg, yield = 79%). 
MS (ESI) [M−I]+ 669.21 
1H NMR (200MHz DMSO-d6), δ: 8.55 – 8.34 (m, 4H), 8.22 (d, J = 9.1 Hz, 2H), 8.09 (d, J = 9.0 Hz, 
2H), 7.77 (dd, J = 14.1, 5.3 Hz, 4H), 6.64 (t, J = 12.4 Hz, 1H), 6.38 (d, J = 14.0 Hz, 2H), 4.28 (t, J = 
6.8 Hz, 4H), 1.92 (s, 12H), 1.32 (t, J = 6.8 Hz, 6H). 
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13C NMR (50MHz, DMSO-d6) δ: 172.75, 152.82, 139.45, 133.12, 132.12, 131.25, 130.16, 129.32, 
125.69 (d, J = 6.5 Hz), 124.03, 117.18, 112.30, 102.50, 50.30, 26.30, 12.06. 
2.4.4. Dye 8 
7-bromo-3-butyl-1,1,2-trimethyl-1H-benzo[e]indol-3-ium iodide (4d) (500 mg, 1.06 mmol), N-
((1E,2E)-3-(phenylamino)allylidene)benzenaminium chloride (3) (137 mg, 0.53 mmol), anhydrous 
sodium acetate (130 mg, 1.59 mmol) and acetic anhydride (15 ml) were introduced in a microwave vial 
and heated at 130°C for 10 min. 8 as a blue powder (369 mg, yield = 82%). 
MS (ESI) [M−I]+ 725.25 
1H NMR (200MHz, DMSO-d6), δ:  8.56 – 8.32 (m, 4H), 8.23 (d, J = 9.1 Hz, 2H), 8.08 (d, J = 8.9 Hz, 
2H), 7.78 (dd, J = 14.4, 5.5 Hz, 4H), 6.67 (t, J = 12.4 Hz, 1H), 6.39 (d, J = 13.8 Hz, 2H), 4.23 (t, 4H), 
1.72 (s, 4H), 1.42 (dd, J = 15.3, 7.5 Hz, 4H), 0.94 (t, J = 7.3 Hz, 6H). 
13C NMR (50MHz, DMSO-d6) δ: 173.99, 153.47, 140.66, 133.85, 132.91, 132.05, 130.99, 130.08, 
126.53, 124.87, 118.04, 113.32, 103.73, 51.10, 43.92, 27.25, 19.91, 14.25. 
2.5. Spectroscopic characterization of the symmetrical cyanines 
2.5.1. UV-Vis spectroscopy 
UV-Vis spectra were recorded on a Shimadzu UV-1700 Pharma Spec using different solvents in order 
to investigate the solvatochromic behavior of the symmetrical cyanines. A stock solution (0.7 mM) in 
absolute ethanol (EtOH) was prepared and diluted solutions in acetone, dimethylformamide (DMF), 
methanol, acetonitrile, tetrahydrofuran (THF), dichloromethane (DCM) and DMSO were analyzed. 
2.5.1.1. Determination of Molar Extinction Coefficient 
A concentrated solution per each dye was prepared by weighting the dyes (5-7 mg) and dissolving them 
in 10 ml of absolute ethanol (EtOH). Three diluted solution (25 ml) of EtOH were prepared by taking 
aliquots (0.2, 0.1 and 0.05 ml) of the stock solution. The diluted solutions were measured by UV-Vis 
spectroscopy (Shimadzu UV-1700) using quartz cuvettes (1 cm pathway length). The absorbance 
intensities of each solution at the λmax were plotted versus the sample concentration. A linear fit was 
applied to determine the molar extinction coefficient (ε) as the slope of the line. The analysis was 
performed in duplicate. The obtained data were considered acceptable when the difference between the 
determined log ε was less or equal to 0.02 in respect to their average. Otherwise new concentrated dye 
stock solution in absolute EtOH was prepared and the protocol repeated. 
 
2.5.2. Fluorescence spectroscopy 
Fluorescence measurements were recorded using a HORIBA Jobin Yvon Fluorolog 2. Diluted solutions 
with absorbance around or lower of 0.1 units were used to avoid the presence of aggregates. 
Fluorescence lifetimes were obtained using a proper NanoLED source (636 nm) and a photon counting 
detector (TBX04). The data were fitted to a single exponential function giving the lifetime. The 
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goodness of the fit was assessed by the chi-squared value of less than 1.05 and a residual trace that was 
symmetric about the zero axes. Fluorescence quantum yields were determined using the same 
instrument with Quanta-φ integrating sphere and De Mello method. The final result is an average of 
three independent measurements. 
2.6. Biological assays 
2.6.1. Cell line and cytotoxicity assay 
The human fibrosarcoma cell line, HT-1080, was obtained from the American Type Culture Collection 
(ATCC, Rockville, MD, USA). HT-1080 cells were grown as a monolayer culture in Eagle’s Minimum 
Essential Medium (EMEM, Sigma-Aldrich, Milano, Italy) supplemented with 10% heat-inactivated 
fetal calf serum, 2 mM L-glutamine, 100 UI/mL penicillin and 100 μg/mL streptomycin (Sigma-
Aldrich), at +37°C in a humidified atmosphere of 5% CO2 in air. HT-1080 cells in the exponential 
growth phase were detached using 0.05% trypsin-0.02% EDTA solution (Sigma-Aldrich), resuspended 
in culture medium and seeded at the appropriate cell concentration for cell culture experiments.  
The WST-1 cell proliferation assay was used to evaluate the cytotoxic effect on HT-1080 cells of 
cyanine dyes, i.e., 5, 7, 6 and 8, to select the concentration suitable for the in vitro PDT. Specifically, 
1.5x103 cells were seeded in 100 μL of culture medium in replicates (n = 8) in 96-well culture plates 
(TPP, Trasadingen, Switzerland), and after 24 h of cell growth the medium was removed, and the cells 
incubated with experimental media of differing cyanine dyes’ concentrations (1, 10, 50 and 100 nM). 
The WST-1 reagent (Sigma-Aldrich, 10 μL/100 L) was added at 24, 48, and 72 h and the plates were 
incubated at +37°C in 5% CO2 in air for 1.5 h. The well absorbance was measured at 450 and 620 nm 
(reference wavelength) in a microplate reader (Asys UV340; Biochrom, Cambridge, UK). 
2.6.2. Flow cytometric analysis 
The cellular uptake of cyanine dyes, i.e., 5, 6, 7 and 8, was evaluated by a flow cytometric analysis (BD 
Accuri C6, Becton, Dickinson Bioscience, Milano, Italy). Briefly, 1.5 x 105 cells were plated in 6-well 
culture plates (TPP) and after 24 h incubated with cyanine dyes at the maximum non-cytotoxic 
concentration tested (10 nM) for 1, 4 and 24 h. Cells were then detached after each incubation period 
using a 0.05% trypsin-0.02% EDTA solution (Sigma Aldrich) and re-suspended in 300 L of phosphate 
buffered solution (PBS, Sigma Aldrich). Cells were then run on the flow cytometer considering 10,000 
events at a 640 nm excitation to measure the intracellular dye.  
Reactive oxygen species (ROS) production was evaluated 1, 5, 15, 30, 45, 60 min after the in vitro PDT 
with the different cyanine dyes carried out as described below. HT-1080 cells were incubated with 10 
M of 2’,7’-dichlorofluorescein diacetate (DCFH-DA) (Sigma Aldrich) for 30 min, 1 h after incubation 
with cyanine dyes, i.e., 5, 6, 7 and 8 at 10 nM. After the in vitro PDT, cells were analyzed for ROS 
production by flow cytometry evaluating 10,000 events at a 488 nm excitation. ROS production was 
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expressed as integrated median fluorescence intensity (iMFI), which is the product of the frequency of 
ROS-producing cells and the median fluorescence intensity of the cells. 
 
2.6.3. In vitro photodynamic treatment 
HT-1080 cells in the exponential phase were pre-incubated in the dark for 1 h, the time needed for an 
efficient internalization, in a culture medium containing cyanine dyes at 10 nM, i.e., the maximum non-
cytotoxic concentration tested. Cells were removed from the flask after incubation using a 0.05% 
trypsin-0.02% EDTA solution (Sigma Aldrich) and normalized to 1.5 x 105 cells in 1 mL of PBS in 
polystyrene tubes (TPP). The light-emitting source was based on a light beam (LB), specifically a red 
LED with a wavelength of 636 nm and energy fluency rates adjusted to 15 mW/cm2. Briefly, cellular 
suspensions were exposed to the LB for 20 min in a dark box. After PDT, 1.5 x 103 cells were plated in 
a 96-well culture plate (TPP) and cell proliferation was evaluated at 24, 48 and 72 h using the WST-1 
cell proliferation reagent (10 L/100 L). Cell proliferation data are expressed as a percentage of the 
absorbance of treated cells vs untreated cells. 
 
2.6.4. Statistical analysis 
Data are shown as average values of three independent experiments ± standard deviation. Statistical 
analyses were performed using Graph-Pad Prism 5.0 software (La Jolla, CA, USA); one-way and two-
way analyses of variance and Bonferroni’s test were used to calculate the threshold of significance. 




3. Results and discussion 
3.1. Synthesis 
The synthesis of symmetrical brominated and non-brominated pentamethine cyanine dyes involved the 
condensation of the quaternary heterocyclic salts, bearing an activated methyl group, with 
malonodialdehyde derivatives.[24] While 1,1,2-trimethyl-1H-benzo[e]indole (2a) is commercially 
available, the 7-bromo-1,1,2-trimethyl-1H-benzo[e]indole (2b) was readily obtained exploiting the 
Fischer indole synthesis by reacting (6-bromonaphthalen-2-yl)hydrazine with 3-methylbutan-2-one in 
glacial acetic acid, as previously described for the reported bromoindolium iodide[26] and 
carboxybenzoindolium iodide[27] (see Scheme 1). The subsequent quaternization of the 
benzoindolenine ring, performed under microwave irradiation[26,27], led to an increased acidity of the 
methyl group which enabled the cyanine bridge formation (see first step in Scheme 2). 
 
Scheme 1. Synthesis of bromobenzoindolenine. Experimental conditions: (i) hydrazine hydrate, 0°C; 
125°C, 24 h; (ii) 3-methylbutan-2-one, glacial acetic acid, MW, 10 min, 160°C. 
The characterization of quaternarized salts of 1,1,2-trimethyl-1H-benzo[e]indole (4a-b) matched the 
previously reported in literature.[25] All the symmetrical cyanine dyes were synthesized in a one-step 
reaction under microwave heating following a green method published by Owens et al.[28] by reacting 
two equivalents of quaternary heterocyclic salts with the malonoaldehyde 
bis(phenylimine)monohydrochloride (3) in the presence of sodium acetate and acetic anhydride (see 
Scheme 2). The reaction mixture was finally poured in diethyl ether to precipitate a blue solid, which 
was washed and filtered. Unreacted sodium acetate crystals were then removed by DCM. Finally, 
cyanine dyes were obtained in good yields (79-86%). 
 
Scheme 2. Synthesis of 5, 6, 7 and 8 dyes. Experimental conditions: (i) anhydrous acetonitrile, 





3.2. Spectroscopic characterization of the symmetrical cyanine dyes 
All compounds show a narrow absorption band in the NIR, perfectly matching the phototherapeutic 
window, with the hypsochromic shoulder typical for cyanine dyes. The electronic absorption and 
emission spectra of the compounds, in EtOH, are depicted in Figure 2 while the main photophysical 
parameters in EtOH and DMSO are reported in Table 1 and 2. Different substituents (i.e., presence or 
absence of Br and length of the alkyl chain) on the benzoindolenine ring have no effect on the max 
suggesting that the electronic levels, involved in the π-π* transition, have similar energies.[29] All the 
compounds are characterized by an absorption maximum around 680-695 nm and molar extinction 
coefficient varying from 160,000 to 225,000 M−1cm−1. 
The solvatochromic effect on the compounds absorption spectra was also investigated as depicted in 
Figure 3 for dye 5. As general trend, neither the absorption maxima nor the band shape are affected by 
the solvent polarity. DCM induces a 15 nm bathochromic shift in comparison to MeOH suggesting a 
more polar ground state in comparison to the excited one. No significant differences were observed in 
the absorption peak maxima in protic or aprotic solvents. Similar effect was recorded in the emission 
spectra. Moreover, the low Stokes shift (20 nm) value indicates that a moderate geometry change occurs 
from the ground to the excited state. 
Fluorescence lifetimes (τf) show monoexponential decay and are in the ns range. The alkyl chain length 
on the benzoindolenine ring slightly influences τf. A small τf increase is evident with longer chains, both 
on brominated and non-brominated dyes. The fluorescence quantum yield shows an opposite behaviour 
varying from 29 to 38% as expected for cyanine dyes. 









































Figure 2. Normalized UV-Vis and fluorescence spectra of the synthesized symmetrical cyanine dyes 
















5 682 1.60∙105 702 20 
6 684 1.88∙105 704 20 
7 685 2.25∙105 705 20 
8 688 2.08∙105 709 21 
 
Table 2 
Fluorescence lifetime and quantum yields of symmetrical cyanine dyes in DMSO. 









5 686 705 19 30.2 1.31 
6 689 709 20 29.1 1.42 
7 689 709 20 38.1 1.45 
8 692 713 19 36.5 1.57 
 
Figure 3. Solvatochromic behavior of dye 5. 
 
3.3. In vitro photodynamic activity 
3.3.1. Effect of cyanine dye-based photodynamic treatment on HT-1080 cell proliferation 
HT-1080 cells were exposed to increasing concentration (1, 10, 50 and 100 nM) of each cyanine dye, 
i.e., 5, 6, 7 and 8, to determine the maximum non-cytotoxic concentration suitable for performing the 
in vitro PDT. A dose-dependent cytotoxicity was observed for all the cyanine dyes (Figure 4). All the 


















































cyanine dyes induced a decrease of HT-1080 cell proliferation after 48 h of incubation at the highest 
concentration of 100 nM (5 p < 0.01; 7, 6 and 8 p < 0.001), while at 50 nM the decrease of cell 
proliferation was of course more modest (5 p < 0.01; 7 and 6 p < 0.001). Interestingly, 6 was the only 
dye that induced a significant cytotoxicity already after 24 h of incubation either at 50 nM (p < 0.01) 
and 100 nM (p < 0.001). On the other hand, the brominated derivative 8 almost unaffected HT-1080 
cell proliferation until 72 h of incubation at 50 nM and produced a lower decrease of cell proliferation 
at 100 nM when compared to the other cyanines. Based on these results, the highest non-cytotoxic 
concentration was 10 nM for all the examined cyanine dyes (Figure 4). 
 
Figure 4. Effects of cyanine dyes on HT-1080 cell proliferation. Cell proliferation, after exposure to 
increasing concentrations of cyanine dyes (1, 10, 50, 100 nM), was evaluated at 24, 48 and 72 h by 
WST-1 assay. Statistical significance vs untreated cells: **p < 0.05, **p < 0.01, ***p < 0.001. 
The HT-1080 cell uptake of cyanine dyes was then evaluated cytofluorimetrically after 1, 4 and 24 h of 
incubation of the cells with the minimum non-cytotoxic concentration i.e. 10 nM. All the cyanine dyes 
were efficiently internalized by HT-1080 cells just after 1 h of incubation (Figure 5), suggesting a rapid 





Figure 5. Flow cytometric analysis of cyanine dyes’ cell uptake. HT-1080 cells were incubated with 
cyanine dyes at the same concentration (10 nM) for 1 h. Fluorescent signal was detected using a flow 
cytometer at 640 nm excitation (FL4) to measure the cellular cyanine dye fluorescence with respect to 
untreated cells (control cells). 
Once obtained the minimum non-cytotoxic concentration and the specific time for cyanine dyes uptake, 
the potential photocytotoxicity of each cyanine dye was evaluated by performing an in vitro 
photodynamic treatment. 
The light-induced cytotoxic effect of each cynine dye was observed up to 72 h after the photodynamic 
treatment. While HT-1080 cell proliferation was unaffected by control treatments, i.e., exposure to 
cyanine dye (10 nM) or light beam alone (LB, 15 mW/cm2 for 20 min), a cytotoxic photodynamic effect 
was observed with each cyanine dye, becoming more significant at 72 h after PDT. In comparison to 
untreated HT-1080 cells, a slight cell proliferation reduction was observed for 5 (70.9% ± 18.3%, p < 
0.05) while stronger reduction was reported with 7 (53.6% ± 13.3%, p < 0.001), 6 (49.1% ± 10.2%, p 
< 0.001) and 8 (56.7% ± 10.5%, p < 0.001) 72 h after PDT. Surprisingly, a very small difference in the 
photoactivity behavior was found when comparing 6 with the brominated analog 8. The heavy atom 
effect on the PDT activity is well-known documented for similar series of indolenine based cyanine[19] 
and squaraine dyes.[20] This different behaviour could be explained by the relative position of the 
bromine on the dye structure. The heavy atom effect is remarkable when directly linked to an indolenine 
ring. In the present work the bromine atom is on a benzoindolenine structure. We speculate that this 
position could have certain effect on the distance and on the effect on the dye photoactivity. On the 





Figure 6. Effect of photodynamic treatment on HT-1080 cell proliferation. Cells were incubated for 1 
h with different cyanine dyes at the same concentration (10 nM) and then exposed to PDT with a light 
beam (LB, 636 nm) at 15 mW/cm2 for 20 min. Cell proliferation was evaluated after 24, 48 and 72 h by 
WST-1 assay. Statistically significant difference vs untreated cells: *p < 0.05, ***p < 0.001. 
3.3.2. Effects of cyanine dye-based photodynamic treatment on reactive oxygen species production 
DCFH-DA (2’,7’-dichlorofluorescin diacetate) was used as ROS probe to evaluate the intracellular 
ROS generation after PDT by flow cytometry. Highly fluorescent DCF is generated in presence of 
peroxides and can be excited at 488 nm where the synthetized cyanine dyes do not absorb light. 5 
showed a different ROS generation pattern with respect to other cyanine dyes, maybe in line with its 
different photodynamic cytotoxic effect. An increased intracellular production of ROS, reaching a 
maximum 45 minutes after the photodynamic treatment was observed upon irradiation at proper 
wavelength of 5. On the other hand, 7, 6 and 8 showed a rapid increase in ROS production after the 
photodynamic treatment with a reaching the highest ROS value after 1, 15 and 1 min, respectively. 
Similar ROS production decrease that reset after 45 min from the photodynamic treatment was observed 
for 7 and 8. 
It is worth noting that the cyanine dyes which produce higher values of ROS in the shorter time in i.e., 
7, 8 and 6, are the more photo-cytotoxic in the in vitro PDT treatment (Figure 6). Finally, it has to be 
pointed out that the highest ROS production values were obtained by treatment with 5 and 7 45 and 1 





Figure 7. HT-1080 reactive oxygen species (ROS) production after PDT. HT-1080 cells were exposed 
to PDT with a light beam (LB, 636 nm) at 15 mW/cm2 for 20 min, alone or after cell incubation for 1 h 
with cyanine dyes at the same concentration (10 nM). ROS levels were determined according to the 
dichlorofluorescin-diacetate assay by flow cytometry and expressed as the integrated median 
fluorescence ratio (iMFI), as described in Materials and Methods. 
4. Conclusions 
We have reported the synthesis of new symmetrical brominated and non-brominated penthametine 
cyanine dyes varying the alkyl chain lengths which confer different lipophilicity characteristics. The 
absorption maxima around 680-695 nm are not affected by the different substituent on the 
benzoindolenine ring (i.e. length of the alkyl chain). We have demonstrated that, different from other 
reported photosensitizers, the presence of a heavy atom such bromine has no remarkable influence on 
the photodynamic effect for this series of probes. All the tested cyanine dyes show a certain 
phototoxicity which is slightly higher for the brominated-cyanine with longer alkyl chain (four carbons). 
Moreover, both brominated and non-brominated benzoindolenine-based cyanines were able to produce 
ROS and were efficiently internalized by HT-1080 cells just after 1 h of incubation. To our surprise, 
the presence of bromine on the benzoindolenine ring was depicted by a faster rate of ROS production 
but has no effect on the photoactivity experiments. This behavior can be explained by the different 
position of the heavy atom with respect to the other series of polymethine dyes reported in literature. It 
is worth noting that these molecules are active at very low concentration (10 nM), making them suitable 
and appealing for in vivo application with the possibility of low dose effectiveness. 
Acknowledgements 
Authors acknowledge the financial support from the University of Torino (Ricerca Locale ex-60%, 
Bando 2016). 
References 
[1] Luo S, Zhang E, Su Y, Cheng T, Shi C. A review of NIR dyes in cancer targeting and imaging. 
16 
 
Biomaterials 2011;32:7127–38. doi:10.1016/j.biomaterials.2011.06.024. 
[2] Fabian J, Nakazumi H, Matsuoka M. Near-Infrared Absorbing Dyes. Chem Rev 
1992;92:1197–226. doi:10.1021/cr00014a003. 
[3] Zhang C, Liu T, Su Y, Luo S, Zhu Y, Tan X, et al. A near-infrared fluorescent heptamethine 
indocyanine dye with preferential tumor accumulation for in vivo imaging. Biomaterials 
2010;31:6612–7. doi:10.1016/j.biomaterials.2010.05.007. 
[4] Pauli J, Vag T, Haag R, Spieles M, Wenzel M, Kaiser WA, et al. An in vitro characterization 
study of new near infrared dyes for molecular imaging. Eur J Med Chem 2009;44:3496–503. 
doi:10.1016/j.ejmech.2009.01.019. 
[5] Shimi M, Sankar V, Rahim MKA, Nitha PR, Das S, Radhakrishnan K V., et al. Novel 
glycoconjugated squaraine dyes for selective optical imaging of cancer cells. Chem Commun 
2017;53:1–4. doi:10.1039/c6cc10282d. 
[6] Bertolino CA, Caputo G, Barolo C, Viscardi G, Coluccia S. Novel heptamethine cyanine dyes 
with large stoke’s shift for biological applications in the near infrared. J Fluoresc 
2006;16:221–5. doi:10.1007/s10895-006-0094-8. 
[7] Miletto I, Gilardino A, Zamburlin P, Dalmazzo S, Lovisolo D, Caputo G, et al. Highly bright 
and photostable cyanine dye-doped silica nanoparticles for optical imaging: Photophysical 
characterization and cell tests. Dye Pigment 2010;84:121–7. 
doi:10.1016/j.dyepig.2009.07.004. 
[8] Avirah RR, Jayaram DT, Adarsh N, Ramaiah D. Squaraine dyes in PDT: from basic design to 
in vivo demonstration. Org Biomol Chem 2012;10:911. doi:10.1039/c1ob06588b. 
[9] Shi C, Wu JB, Pan D. Review on near-infrared heptamethine cyanine dyes as theranostic 
agents for tumor imaging, targeting, and photodynamic therapy. J Biomed Opt 2016;21:50901. 
doi:10.1117/1.JBO.21.5.050901. 
[10] Barbero N, Visentin S, Viscardi G. The different kinetic behavior of two potential 
photosensitizers for PDT. J Photochem Photobiol A Chem 2015;299:38–43. 
doi:10.1016/j.jphotochem.2014.11.002. 
[11] Miletto I, Fraccarollo A, Barbero N, Barolo C, Cossi M, Marchese L, et al. Mesoporous silica 
nanoparticles incorporating squaraine-based photosensitizers: a combined experimental and 
computational approach. Dalt Trans 2017:15–8. doi:10.1039/C7DT03735J. 




[13] Plaetzer K, Krammer B, Berlanda J, Berr F, Kiesslich T. Photophysics and photochemistry of 
photodynamic therapy: Fundamental aspects. Lasers Med Sci 2009;24:259–68. 
doi:10.1007/s10103-008-0539-1. 
[14] Macdonald I, Dougherty T. Basic principles of photodynamic therapy. J Porphyrins 2001:105–
29. 
[15] Ogilby PR. Singlet oxygen: there is indeed something new under the sun. Chem Soc Rev 
2010;39:3181. doi:10.1039/b926014p. 
[16] Ormond AB, Freeman HS. Dye sensitizers for photodynamic therapy. Materials (Basel) 
2013;6:817–40. doi:10.3390/ma6030817. 
[17] Baldassarre F, Foglietta F, Vergaro V, Barbero N, Capodilupo AL, Serpe L, et al. 
Photodynamic activity of thiophene-derived lysosome-specific dyes. J Photochem Photobiol B 
Biol 2016;158:16–22. doi:10.1016/j.jphotobiol.2016.02.013. 
[18] Dichiara M, Prezzavento O, Marrazzo A, Pittalà V, Salerno L, Rescifina A, et al. Recent 
advances in drug discovery of phototherapeutic non-porphyrinic anticancer agents. Eur J Med 
Chem 2017. doi:10.1016/j.ejmech.2017.08.070. 
[19] Atchison J, Kamila S, Nesbitt H, Logan KA, Nicholas DM, Fowley C, et al. Iodinated cyanine 
dyes: a new class of sensitisers for use in NIR activated photodynamic therapy (PDT). Chem 
Commun 2017;53:2009–12. doi:10.1039/C6CC09624G. 
[20] Serpe L, Ellena S, Barbero N, Foglietta F, Prandini F, Gallo MP, et al. Squaraines bearing 
halogenated moieties as anticancer photosensitizers: Synthesis, characterization and biological 
evaluation. Eur J Med Chem 2016;113:187–97. doi:10.1016/j.ejmech.2016.02.035. 
[21] Yang X, Shi C, Tong R, Qian W, Zhau HE, Wang R, et al. Near IR heptamethine cyanine dye-
mediated cancer imaging. Clin Cancer Res 2010;16:2833–44. doi:10.1158/1078-0432.CCR-
10-0059. 
[22] Wang Y, Liu T, Zhang E, Luo S, Tan X, Shi C. Preferential accumulation of the near infrared 
heptamethine dye IR-780 in the mitochondria of drug-resistant lung cancer cells. Biomaterials 
2014;35:4116–24. doi:10.1016/j.biomaterials.2014.01.061. 
[23] Onoe S, Temma T, Shimizu Y, Ono M, Saji H. Investigation of cyanine dyes for in vivo 




[24] Pisoni DS, Ce A, Borges A, Petzhold CL, Rodembusch FS, Campo LF. Symmetrical and 
Asymmetrical Cyanine Dyes. Synthesis, Spectral Properties, and BSA Association Study 
2014. 
[25] Winstead AJ, Nyambura G, Matthews R, Toney D, Oyaghire S. Synthesis of quaternary 
heterocyclic salts. Molecules 2013;18:14306–19. doi:10.3390/molecules181114306. 
[26] Barbero N, Magistris C, Park J, Saccone D, Quagliotto P, Buscaino R, et al. Microwave-
assisted synthesis of near-infrared fluorescent indole-based squaraines. Org Lett 
2015;17:3306−3309. 
[27] Park J, Barbero N, Yoon J, Dell’Orto E, Galliano S, Borrelli R, et al. Panchromatic 
symmetrical squaraines: a step forward in the molecular engineering of low cost blue-greenish 
sensitizers for dye-sensitized solar cells. Phys Chem Chem Phys 2014;16:24173–7. 
doi:10.1039/C4CP04345F. 
[28] Owens EA, Bruschi N, Tawney JG, Henary M. A microwave-assisted and environmentally 
benign approach to the synthesis of near-infrared fluorescent pentamethine cyanine dyes. Dye 
Pigment 2015;113:27–37. doi:10.1016/j.dyepig.2014.07.035. 
[29] Bertolino CA, Ferrari AM, Barolo C, Viscardi G, Caputo G, Coluccia S. Solvent effect on 
indocyanine dyes: A computational approach. Chem Phys 2006;330:52–9. 
doi:10.1016/j.chemphys.2006.07.045. 
 
